Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Symons

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 5, 2023
Perivascular spaces mediate a relationship between diabetes and other cerebral small vessel disease markers in cerebrovascular and neurodegenerative diseasesJulia Zebarth, Radia Kamal, George Perlman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 19, 2024
Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseasesWilliam Z Lin, Di Yu, Lisa Y Xiong, et al.
Journal of the American Heart Association|December 30, 2022
Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in StrokeDi Yu, Nuanyi Liang, Julia Zebarth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2024
Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseasesDaniela Andriuta, Julie Ottoy, Myuri Ruthirakuhan, et al.
Neurorehabilitation and Neural Repair|June 3, 2023
Association of Dual-Task Gait Cost and White Matter Hyperintensity Burden Poststroke: Results From the ONDRIFrederico Pieruccini-Faria, Benjamin Cornish, Malcolm Binns, et al.
International Journal of Geriatric Psychiatry|March 16, 2024
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal studyNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
European Journal of Neurology|January 24, 2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research InitiativeDaniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Yanina Sarquis-Adamson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseasesAllison A Dilliott, Stephanie A Berberian, Kelly M Sunderland, et al.
Geroscience|March 16, 2022
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Alzheimer'S Research & Therapy|June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 5, 2023
Perivascular spaces mediate a relationship between diabetes and other cerebral small vessel disease markers in cerebrovascular and neurodegenerative diseasesJulia Zebarth, Radia Kamal, George Perlman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 19, 2024
Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseasesWilliam Z Lin, Di Yu, Lisa Y Xiong, et al.
Journal of the American Heart Association|December 30, 2022
Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in StrokeDi Yu, Nuanyi Liang, Julia Zebarth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2024
Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseasesDaniela Andriuta, Julie Ottoy, Myuri Ruthirakuhan, et al.
Neurorehabilitation and Neural Repair|June 3, 2023
Association of Dual-Task Gait Cost and White Matter Hyperintensity Burden Poststroke: Results From the ONDRIFrederico Pieruccini-Faria, Benjamin Cornish, Malcolm Binns, et al.
International Journal of Geriatric Psychiatry|March 16, 2024
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal studyNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
European Journal of Neurology|January 24, 2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research InitiativeDaniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Yanina Sarquis-Adamson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseasesAllison A Dilliott, Stephanie A Berberian, Kelly M Sunderland, et al.
Geroscience|March 16, 2022
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Alzheimer'S Research & Therapy|June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Pageof 9